TSLA
Tesla
-- 431.660 RGTI
Rigetti Computing
-- 17.0800 NVDA
NVIDIA
-- 137.010 LAES
SEALSQ Corp
-- 9.080 PLTR
Palantir
-- 79.080 
📖Introduction of Heartseed Company📖 (October 15, 2024)
On October 12, on TV Tokyo's "Breakthrough," there was an introduction of the growth stock (219A) Heartseed, so let's collaborate!
President Fukuda is an honorary professor at Keio University School of Medicine and a specialist in hearts. He envisions simple treatment for the world's leading cause of death, heart failure, with a new treatment method about to be put into practical use!
🟦New Treatment for Heart Failure
- Create myocardial cells (top secret) from IPS cells and transplant them into the patient's heart! ❗
Developed a special needle (top secret) for injecting into the heart.
Developing a simple procedure of inserting a catheter from the waist without opening the chest (top secret).
- Create myocardial cells (top secret) from IPS cells and transplant them into the patient's heart! ❗
Developed a special needle (top secret) for injecting into the heart.
Developing a simple procedure of inserting a catheter from the waist without opening the chest (top secret).
🟦 Current situation
Confirmed improvement of symptoms in heart failure patients through myocardial cell transplantation in clinical trials!
Currently conducting clinical trials on simple transplantation using a catheter!
Novo Nordisk partners! (Investment of 65.5 billion yen)
Currently conducting clinical trials on simple transplantation using a catheter!
Novo Nordisk partners! (Investment of 65.5 billion yen)
Above was Neko Kumamon Mon.
(By the way, on 2024/10/15, straight into Heartseed! 😂😂)
(By the way, on 2024/10/15, straight into Heartseed! 😂😂)
(Posted on October 15, 2024)
------------(Added on 10/21/2024)------------
On August 26, 2024, on a TV program ✨
Introduction video of Heartseed
Existed‼️
• Okamura, who loves festivals, developed severe heart failure. Therefore, after receiving the clinical trial treatment of IPS myocardial cell injection technology unique to Heartseed's world, it became normal!
The practical application of this technology is scheduled for 2027. Various tests are being conducted regarding quality degradation due to transportation, and so on.
The practical application of this technology is scheduled for 2027. Various tests are being conducted regarding quality degradation due to transportation, and so on.
(Added on 21 October 2024)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
ネコくまモン OP :
Progress records (2024/10/15)
After getting higher, put the place where it came down to Heartseed.
ネコくまモン OP :
Progress Report (2024/10/21)
Today, the pharmaceutical sector seems to be in a selling trend, with the daily chart breaking below the resistance level, facing headwinds. Once the resistance level is broken, cut losses by 100%!
ネコくまモン OP :
Progress record (12/27/2024)
(9:23)Heartseed is rising aiming for the previous high!
With the daily flag breakout, Heartseed has entered an upward trend and is currently back IN, but will it break through the high of 2830 by the end of the year
It would be great if it breaks through! Even if it doesn't, that's something to look forward to in the future! w,ww